Figure 7. (C) 2-d AIFy/+ EBs were treated with or without 2 µM EUK134 for 24 h. Immunoblots show that EUK134 treatment reduced the expression of HIF-1α, HIF-2α, Bnip3, and cleaved caspase-3.
Figure 7.

(C) 2-d AIFy/+ EBs were treated with or without 2 µM EUK134 for 24 h. Immunoblots show that EUK134 treatment reduced the expression of HIF-1α, HIF-2α, Bnip3, and cleaved caspase-3.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal